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PHEOCHROMOCYTOMA - A SURVEY OF CURRENT CONCEPTS
HENRV L . GREEN,

M.D.*

A considerable amount of information is now available about the physiology,
clinical behavior, and management of pheochromocytoma. Unfortunately, much of
this data is so widely scattered through the literature that it is accessible only by
time-consuming search. The author has attempted to bring it together. A few of
the less common features are included for their interest. No pretense of exhaustiveness
is made, although many of the articles referred to are themselves reviews.
HISTORY
The first pathological description of what was probably a pheochromocytoma
was published by Frankel in 1886.'^ Labbe" is credited with recognition of the
syndrome of paroxysmal hypertension associated with these tumors. Ante-mortem
diagnosis was first accomplished by Vaquez in 1926." Charies Mayo first excised
such a neoplasm, apparently without realizing what it was." In 1929, Pincoffs was
able to predict the presence of a pheochromocytoma, the diagnosis being later confirmed at surgery.^'
TERMINOLOGY
The terms pheochromocytoma and chromaffinoma refer to the functioning tumor
of the adrenal medulla. They may also be used to designate ectopic chromaffin tumors.
Paraganglioma is used synonymously by some authors, while others apply it only to
the extra-adrenal chromaffinomas. Formerly it was thought that the carotid body
tumor and related neoplasms were also paragangliomas. These have since been shown
to be neither chromaffin positive nor of ectodermal origin. Carcinoid tumors have
also been considered paragangliomas in the past."
INCIDENCE
Approximately 400 cases of pheochromocytoma have been reported. This figure
belies their true incidence. For example, Graham" found 8 pheochromocytomas in
the course of 1700 sympathectomies performed on hypertensive patients (0.47%).
The sex incidence is about equal, except in childhood when boys predominate.^-'^
It is found at any time of life, from infancy to old age, but most often between 20
and 40 years.'-^"'" A familial occurrence has sometimes been noted, especially for
tumors involving the organs of Zuckerkandl, and for those associated with neurofibromatosis.'" About one tenth of the reported cases have been in pregnant women."
PATHOLOGY
Pheochromocytomas may develop wherever chromaffin tissue occurs, either
embryrologically or in the adult." The commonest location is in or about the adrenal
( 8 2 % ) , particulariy the right one.^'-" They also found along the cerival, thoracic,
or abdominal sympathetic chain.'" In the chest they may be seen roentgenographically
as paravertebral masses even before the onset of symptoms." They are also located
along the major vessels of the abdomen (presumably arising from the organs of
Zuckerkandl and other bodies) and the mesentery of the small intestine."-'' Very
rarely they occur in the urinary bladder,''-'" or intracranially.'"
* Division of Cardiovascular Disease
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About 10% are bilateral." In children both multiple and extra-adrenal tumors
are considerably more common.'^
Their size varies from the microscopic (detectable only by the effect of surgical
manipulation of the affected adrenal)" to huge masses weighing up to 8 pounds.^-"-""
The majority weigh less than 100 grams."" A t operation a peculiar brown pigmentation of the perirenal fat may be seen." Benign chromaffinomas are well encapsulated,
compressing but not invading the neighboring organs. Cystic and necrotic areas in
the tumor reflect its great metabolic demand. Calcification is sometimes seen, even
on x-ray.'-'-"
Microscopically the architecture is variable even within the same tumor. Nests,
trabeculae, cords or other arrangements of cells lie in the highly vascular stroma.
The cells are large but tend to resemble those of the adrenal medulla. Lipochrome
and brown pigment are seen in the cytoplasm in chromate fixed specimens. Multiple
infarcts are common.'-"
The affinity for chrome salts has been directly attributed to the catecholamine
content of the tissue. Chemical analysis of chromaffin tumors has repeatedly confirmed this correlation. However, a patient was recently cured of hypertension by
surgical removal of a non-chromaffin paraganglioma from the aortic bifurcation.
Analysis of both the patient's urine and the tumor revealed large amounts of catecholamines."
About 10% of pheochromocytomas are malignant.'-"-'" The incidence is higher
for bilateral tumors and for those associated with persistent hypertension." Metastases
occur to liver, lungs, bones, regional lymph nodes, and other organs.' As with other
endocrine tumors, malignancy is very difficult to assess histologically, and those originally considered benign may later be found to have metastasized."
PATHOLOGIC PHYSIOLOGY
The clinical features associated with these tumors are due to their secretion of
biologically active chemicals and to their mechanical effects. In most cases the
hormones produced are mainly epinephrine and norepinephrine. The latter usually
accounts for the greater fraction.'-'" However, neoplasms containing large amounts
of 3-hydroxytryptamine and DOPA have been described."'
There is only a crude relationship between the chemical nature of the secretions
and the clinical picture produced. Pharmacologically, epinephrine is known to raise
the systolic blood pressure and pulse rate. Elevation of the blood sugar, hypermetabolism, apprehension, mydriasis, and other phenomena are also produced. Norepinephrine increases both systolic and diastolic blood pressure, slows the pulse, and has
far less effect on the other body processes. Thus a small chromaffinoma producing
mainly norepinephrine gives rise to the clinical picture of essential hypertension,
while epinephrine secreting tumors are apt to be associated with nervousness, palpitation, diabetes, etc. However, large doses of epinephrine will elevate the diastolic
pressure, and large doses of norepinephrine produce metabolic symptoms. The ratio
of the concentrations of the two hormones also seems to play a part.'-'-"' Following
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the removal of a malignant pheochromocytoma its metastases may continue to
elaborate pressor substances."'
In the metabolism of epinephrine and norepinephrine, they are apparently converted into their 3-methoxy derivatives. Unlike their parent compounds, these substances are effective substrates for monoamine oxidase. This enzyme converts them
into 3-methoxy-4-hydroxy mandelic acid (vanillylmandelic acid, V . M . A . ) . This is
excreted in the urine along with the glucuronides of 3-methoxy epinephrine and 3methoxynorepinephrine. Only a small percentage of the epinephrine and norepinephrine
is excreted unchanged.'"
C L I N I C A L FEATURES
An impressive variety of syndromes may be produced in different patients. In
70% of cases there is sustained hypertension. Upon this there may or may not
be superimposed paroxysms of increased blood pressure and metabolic activity. Less
often the "classical picture" is seen, with normal blood pressure between crises."-"-"'-""-"'
Almost any of the symptoms may so dominate the illness as to make the diagnosis
obscure. Recurrent vomiting,'" abdominal symptoms,'" or night sweats"' may be the presenting difficulty. The patient may develop a myocardial infarction, a stroke, or pulmonary edema without ever having had previous evidence of the tumor.'"-" On the
other hand, asymptomatic pheochromocytomas have been discovered during surgery
for some unrelated condition."" Usually the patient has had difficulty for a period
of 6 weeks to 10 years." Moore'" has emphasized the great difficulty of eliciting
the symptoms even when they are present.
In childhood the picture is about the same as in the adult, except that hypertension
is almost invariably sustained.""
Table 1 presents a list of the commoner symptoms in approximate order of
frequency." Obviously the variations which may occur from patient to patient are
innumerable.
Table 1
Common symptoms of pheochromocytoma
Headache (usually pulsating, severe)
Pallor or flushing of face
Palpitation
Dizziness
Vomiting
Substernal pain
Sweating
Abdominal pain
Dyspnea
Nervouseness or anxiety
Weakness
Nausea
Other symptoms include pain and numbness of the legs," tingling and coldness
of the hands and feet," and blurred vision or even blindness." Subjective and objective coldness associated with vasoconstriction is a typical feature." Raynaud's
phenomenon has been described."
Crises may be precipitated by a wide variety of circumstances, commonly involving some change of posture or other mechanical stimulus to the tumor, (Table 2 ) .
Wingo"" has called attention to the fact that many of these stimuli involve a small
initial reduction in blood pressure. He postulates that the attack may represent an
inappropriately dramatic response of the tumor to this hypotension.
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Table 2
Factors Precipitating Paroxysms
Change of posture (bending,
stooping, lateral flexion)
exertion
trauma to side or abdomen
local heat
perirenal air insufflation
general anesthesia
parturition
meals

Alcohol
histamine (as in gastric analysis)
amobarbital sodium sedation
TEA chloride
pain
hyperventilation
emotional stress
postural hypotension
carotid sinus pressure
change ot temperature

Sleep
laughing
sexual intercourse
shaving
gargling
straining at stool
sneezing
having BP taken
urination (pheochromocytoma
of bladder)

The frequency of attacks ranges from several dozen a day to one every few
months. They last from seconds to hours, commonly 10 or 15 minutes. They tend
to increase in frequency but not severity. While the patient is often exhausted
following paroxysms, he may be well between them. Some experience isolated symptoms, varying in severity, beginning and ending gradually, and lasting hours or days.
There may be continuous hypermetabolism and/or hyperglycemia with paroxysmal
hypertension. Severe attacks may end fatally.'-'"-"-'"
As stated, the blood pressure is usually elevated continuously, but paroxysms may
be superimposed. Following an attack, the pressure may return to previous levels
or hypotension of various degrees may occur. Dybkcer' feels that adaptation of the
body to the high concentration of pressor substances accounts for the various sequelae
of an attack. When secretion diminishes slowly, the blood pressure gradually falls
to its former level. With more abrupt fall in concentration, it drops below that level,
but returns spontaneously. A sudden cessation of secretion may result in shock or
even death.
Either systolic or diatolic blood pressure or both may be raised. The pulse rate
may be fast or slow. Postural tachycardia and less reliably postural hypotension have
been considered of diagnostic importance."-"'
Some degree of fever is common, probably because of hypermetabolism coupled
with impaired heat dissipation due to vasoconstriction. Even hyperpyrexia may occur,
especially in the terminal stages."'"-"'
Characteristically the patient is thin." Shivering is not uncommon.' When combined with sweating, a striking picture is produced. There may be pallor, flushing,
or mottling of the face.'-"-'"-"-" The peripheral arteries may be constricted, even to
the point of disappearance of the pulses." The pupils may be dilated.' The fundi
often reflect the degree of hypertension." In addition the retinal vessels may show
constriction."
An abdominal mass, either the tumor itself or a displaced liver or kidney, is
palpable in 15% of cases. Even when it is not, palpation or massage of the flank
may trigger an attack, if the tumor is sufficiently large. This sign should be deliberately sought. A syringe of phentolamine is kept ready for emergency use. I f a
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paroxysm is produced, termination of it by injection of the drug will also be of
confirmatory value.'-'"-"
Certain diseases seem to show a peculiar association with pheochromocytoma.
Five percent of the patients have neurofibromatosis.' Von Hippel-Lindau's disease
(angiomatosis retinae and cerebelli) may occur along with the neoplasm."' There
appears to be an increased incidence of gallstones." Rarely, Cushing's syndrome is
a concomitant."-'"
DIAGNOSIS
There are many circumstances that should call to mind the possibility of
pheochromocytoma. Each author emphasizes a somewhat different set of indications
for applying the screening tests. They may be summarized as follows:'-'-'"-'""-'"-"-"'.
1. In the hypertensive
a. paroxysmal hypertension or wide fluctuation within the hypertensive range
b. hypertension in young individuals, pregnant or puerperal women, or in
the absence of positive family history
c. hyptersion of recent onset
d. severe hypertension
e. hypertension with a normal pressor response
f. hypertension associated with a postural fall in blood pressure and/or rise
in pulse rate
g. paradoxical response to ganglionic blocking agents
h. hypertension associated with diabetes, hypermetabolism, fever, sweating
or neurofibromatosis
2. A rise in blood pressure associated with general anesthesia, when no other
cause is evident. If this occurs, the procedure should be discontinued until
pheochromocytoma has been ruled out, as surgery for unrelated conditions
carries a 50% mortality in the presence of such a neoplasm
3. "Seizures" characterized by any combination of the symptoms previously
mentioned, especially if precipitated by factors such as those listed in Table 2
4. Nervous or hypermetabolic symptoms
5. Headache
6. Shock following the administration of a phenothiazine drug
Kvale states that it is probably rarely necessary to consider the diagnosis in an
obese patient.
DIFFERENTIAL DIAGNOSIS
1. Hypertension due to other causes. While the hypermetabolic, paroxysmal,
and other features of pheochromocytoma are of diagnostic value, their absence does not exclude the diagnosis."-"-"' In sustained hypertension due
to chromaffinoma, the duration of illness is usually much shorter than in
essential hypertension. This is not invariable, however, and the other features
of the two may be identical. Probably almost all hypertensives should be
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screened for pheochromocytoma. As seen, the syndrome must also be distinguished from the toxemias of pregnancy.'-"
2. Hyperthyroidism. Paradoxical weight loss, apprehensiveness, weakness, fine
hair, restlessness, and fine tremor may all be caused by pheochromocytoma.
The BMR is often significantly elevated. At times thyromegaly and exophthalmos compound the difficulty. The blood cholesterol, protein bound
iodine, and radioactive iodine uptake usually help distinguish this syndrome
from thyrotoxicosis, but reportedly the PBI ca nbe elevated in pheochromocytoma. Antithyroid drugs are usually fairly ineffective, but they may cause
a temporary reduction in BMR.'-"-"'
3. Diabetes. During paroxysms elevated blood sugar with diminished glucose
tolerance are common. Insulin resistant diabetes and even acidosis have
been noted, with complete clinical disappearance of the diabetes following
removal of the pheochromocytoma. Any diabetic with severe hypertension
or with retinopathy characteristic of hypertension should be investigated"-'"24,26,48,50 Kimmelstiehl-Wilsou disease may be mimicked.
4. Headache may be the dominant feature. This may resemble a tension
headache or one of the vascular types, such as migraine or histamine cephalalgia..'"-'"-""
5. Other neurological disorders, including stroke, brain tumor, epilepsy, tabes
dorsalis, and "acute nervous system infection or allergy" must be differentiated."-" In children the first impression is frequently that of an intracranial lesion.""
6. Psychosis or neurosis may be the presenting difficulty. This may take
the form of anxiety or hysteria, often with hyperventilation. It may also
resemble menopausal tension, agitated depression, or cyclothymic psychosis.
Hypertension may not be detected.'" Electroshock therapy or other procedures in such patients may, of course, be disasterous.
7. Coronary artery disease, ranging from coronary insufficiency to myocardial
infarction may be imitated or may actually co-exist'"-"-'"
8. Gastrointestinal symptoms may not be very characteristic or may be such
as to lead to the diagnosis of an acute abdominal emergency. Shock and
ileus may accompany severe abdominal pain. Infarction of the tumor is
thought to account for acute pain, whereas chronic symptoms may be
caused by pressure on the surrounding structures. Again, there may be
no evidence of previous or concomitant hypertension.'-'"-"
9. Miscellaneous conditions to be differentiated include the following:"-"-"'
lead poisoning

gastrointestinal hemorrhage

hyperinsulinism

urticaria

various renal lesions,
including glomerulonephritis

angioneurotic edema
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LABORATORY FINDINGS
The routine laboratory tests are not very helpful."-"-'"-"' Albuminuria occurring
after attacks or continuously is found in about two-thirds of cases. The blood sugar
is often elevated; in fact the patient may be frankly diabetic. Serum potassium is
elevated, especially with a paroxysm, owing to the action of epinephrine. The electrocardiogram may show the changes expected with hypertension due to any cause. A
basal metabolic rate as high as 90 or 100 may be found. While classically normal,"'
the cold pressor test has been known to be positive, or even to trigger a crisis."-"'
Kvale'" states that he has not observed this however. The test is almost always
abnormal in essential hypertension. Intravenous pyelography may demonstrate a mass.
PHARMACOLOGIC TESTS
If carefully selected and applied, these are valuable screening procedures. Their
value is limited somewhat by the lack of uniform criteria for the normal limits of
many of the tests.
There are two general types. Blocking tests are used if the patient's blood
pressure is found to be elevated (e.g. over 170/110'°). A substance is administered
which blocks the effect of circulating pressor amines. Provocative tests are intended
to cause a paroxysm in a patient whose blood pressure is normal or only slightly
elevated"' (Kvale says under 170/110). If the pressure fluctuates widely, both
types of tests should perhaps be done at appropriate blood pressure levels.
Certain precautions will enhance the reliability of these procedures. Obviously
one could easily be misled by a difference between the blood pressures in the two
arms. Errors due to spontaneous fluctuations in the pressure should be minimized
by following the basal blood pressure for at least 30 minutes before the test, or at
least by having the patient rest for a similar period. Similarly the blood pressure
should be followed for at least 15 minutes after it has returned to the control level.
A cold pressor test should be done before giving any provocative agent to avoid
misinterpreting the results obtained.'"-"
Many medications are capable of causing false positive or false negative resu'.ts
(see below).
Phentolamine (Regitine) methanesulfonate test: Following rapid intravenous
injection of 5 mgs. of the drug, the blood pressure is taken every 30 seconds for 5
minutes, and then every minute for 15 or 30 minutes, or until it stabilizes at control
levels. A positive result consists of a fall of 35 mms. of systolic and 25 mms. in
diastolic pressure. This usually begins immediately, reaches a nadir in 2 to 5 minutes,
and lasts 10 minutes to an hour or more. Occasionally, a "fall-rebound-fall" response
occurs, which also represents a positive test. A fall the first minute, with return to
basal levels in the next minute is negative.'"-"
False positive phentolamine tests occur in subjects receiving narcotics, sedatives,
rauwolfia compounds, or thiocyanates, and in uremic patients. Sedatives and narcotics
should be stopped for 48 hours, thiocyanates 4 to 6 days, and rauwolfia several
weeks prior to the test. With these precautions, false positive tests are allegedly
rare,'"-'"-"-"-"' although some"' feel they are not unusual.
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False negative tests may be seen in patients being treated with hydralazine and
other antihypertensive drugs. Hydralazine should be discontinued for several weeks,'"
and other drugs for several days.
An intramuscular phentolamine test has also been used, but is probably less
reliable."
Most workers consider Regitine the blocking drug of choice, as it is quite safe.
The side effects are minimal in the recommended dose, consisting of tachycardia,
weakness, dizziness and flushing. The test can even be performed on an emergency
basis in the presence of hypertensive encephalopathy.'" To this author's knowledge,
two fatal reactions have been reported.'"-" Lance'" feels Regitine may be dangerous
in patients with normal basal blood pressures.
Piperoxan (Benodaine) hydrochloride test. This blocking test is performed by
giving 0.25 mgs. per kg. (the maximum 20 mgs.) of the drug intravenously over a
2 minute period. The blood pressure is followed exactiy as in the phentolamine test.
Criteria for a positive test are less well established, but a fall of 35 mms. in systolic
or diastolic pressure has been suggested. Again, a "fall-rebound-fall" response is
positive.
False positive and negative results probably occur under the same circumstances
as in the Regitine test. The drug is not as safe as phentolamine, and side effects may
be serious. In essential hypertension, tachycardia, headache, flushing, anxiety, chest
or abdominal pain, nausea, vomiting, and dizziness may be seen. In these patients
the blood pressure may fall initially, but often rises, at times to dangerous levels.
Encephalopathy, convulsions, and pulmonary edema can occur. For this reason
Orgain" does not recommend the test for routine screening.
An intriguing new test, the piperoxan antidiuresis t e s t , m a k e s use of the
fact that the drug abolishes the diuretic effect of pressor amines. This action is
even more marked than that on the blood pressure. After an overnight fast the
patient drinks a liter of 0.25% sodium chloride solution in 10 minutes. He remains
recumbent, and smoking is prohibited. After voiding, urine is collected at half hour
intervals for 3 or 4 periods. Immediately following the second voiding, 20 mgs. of
piperoxan are injected intravenously over a two minute period. Subsequent urine
collections show a prompt reduction in volume, generally one-third or less the previous
levels, in patients with pheochromocytoma. Control patients actually showed a slight
increase in urinary output. The test is said to be positive even during the normotensive
phase of the disease.
The dibenamine hydrochloride test is relatively more dangerous and less reliable
than the other blocking procedures and is little used.'-"-"'-""-"'
Histamine /e^f."-"-"-"" After stabilization following a cold pressor test, 0.025
to 0.10 mgs. (usually 0.05 mgs.) of histamine base are administered intravenously in
about 0.5 cc. saline with a tuberculin syringe. Regitine is kept ready for emergency
use. Blood pressure is determined every 30 seconds for 5 minutes, and then every
minute for 15 minutes or until it returns to the control level. I f the drug was
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injected into a vein, the blood pressure falls after 30 seconds. If the test is positive,
it then rises rapidly, 60/35 mms. or more higher than the cold pressor response.
This rise occurs one to four minutes after injection and lasts 5 to 15 minutes.
Symptoms of a severe paroxysm appear.
The mechanism of action is not known. It may be direct stimulation of the
tumor, or the paroxysm may be a response to the initial hypotension produced.
This is generally regarded as the most reliable provocative test. False positives
are seldom seen,'" but may occur with larger doses. It may be falsely negative in
patients receiving sedation or anesthesia, or if the control pressure is too high, or
if the drug is injected slowly.
There is some danger in the procedure. The blood pressure may fall perilously
in the absence of a chromaffinoma, or climb to alarming levels in the presence of
one."' A number of deaths have been reported."' Nevertheless, the test is probably
indicated in all pheochromocytoma suspects who have a normal or fluctuating blood
pressure.
The methacholine (Mecholyl) chloride, tetraethylammonium chloride, and DMPP
provocative tests have little to recommend them.'"-'"-"-"'-""
Epinephrine tolerance test. This is rarely used. It is based on the decreased
response to epinephrine shown by patients with pheochromocytoma, probably due
to an adaptation phenomenon.
CATECHOLAMINE ASSAY
Improved and simpler techniques of catecholamine assay are continually being
perfected. The directness of this approach is a clear advantage. Some even believe
that where this method is available the pharmacologic tests are seldom indicated.*'
Urine assay is most commonly done. A normal resting individual excretes
15-30 meg. per 24 hours, 80% of which is norepinephrine. It never exceeds 185 meg.*
In the presence of pheochromocytoma, the range is from 180 to 9000 meg. The increase is usually in the norepinephrine fraction, but can also be epinephrine." Bananas
contain large amounts of norepinephrine and should be withheld for the test.""
Rauwolfia drugs should be stopped for a month prior to urine collection. Many other
substances may interfere with the determination depending on the technque used."
The output is generally high even during normotensive intervals,'-" but may be
normal at these times.'"•'" I f normal, it may reach diagnostic levels under the influence
of histamine or general anesthesia.'
Although the test is believed to be highly specific, catecholamine output is also
somewhat increased in the following conditions:'"
asphyxia
emotional stress
cold exposure
electroshock therapy
myocardial infarction
increased intracranial pressure
Numerous quantitative and semi-quantitative techniques are used, including bioassay, paper chromatography, photofiuorimetry, and chemical analysis."-"-"
*At the Henry Ford Hospital the normal range is up to 300 meg. total catecholamines per 24 hours.^i
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A new method determines the urinary output of V M A (see Pathologic Physiology,
above). It may be a better test, for this metabolite is excreted far more abundantly
than are the pressor amines themselves.""-'"
Blood catecholamine assay is also useful. It is apparently unnecessary to withhold drugs for the test. The level is considered significant when over 3.5 meg. of
epinephrine-like substance per liter of plasma is found. It can be normal in the
presence of a pheochrome tumor,'" but will be found elevated if the blood is obtained
during a histamine-induced paroxysm.'"-" In essential hypertension, the level is
usually less than 3.5 meg. per liter and does not rise significantly after histamine.
The plasma catecholamine content also rises in some patients with renal insufficiency,
increased intracranial pressure and lymphoma. It is uncertain whether the substances
measured in these conditions are the same as those produced by chromaffinomas.
With the fluorescent column technique, hemolysis or icterus wifl produce falsely high
results. Users of epinephrine nebulizers may also have elevated blood catecholamine
levels.'"-"
LOCALIZATION OF T H E TUMOR
Because pheochromocytomas occur in so many locations and may be multiple,
many authors do not consider exact preoperative localization essential. Rather than
subjecting the patient to potentially dangerous procedures, the surgical approach is
such as to permit rather wide exploration. I f the plain abdominal x-ray and intravenous
pyelogram are non-contributory, operation is not delayed.'"-'"-"
Others feel that exact localization is highly desirable. Aortography, presacral or
perirenal oxygen insufflation, retrograde pyelography, selective aortography, and
tomography have been employed. The gas insufflation techniques, at least, are not
without hazard. Another very ingenious method has been devised, whereby blood
is sampled from various parts of the venous system using a catheter under fluoroscopic
control. The relative catecholamine content of the specimens helps locahze the
tumor."'
Interestingly, tumors producing both norepinephrine and epinephrine tend to lie
in connection with one of the adrenal glands. Those elaborating norepinephrine alone
are usually ectopic."'
TREATMENT
The only successful form of treatment is surgical removal of the tumor. X-ray
therapy has been disappointing."
Preoperatively it may be necessary to control dangerous swings in blood pressure."'
Phentol amine methanesulfonate is apparently of great value here. In one case"' a
continuous infusion of the drug not only prevented the hypertensive crises, but
eliminated the intervening periods of shock. Surgery was then carefully planned
and carried out two and a half days later. These workers used a concentration of
30 mgs. per hter, given intravenously at 20-80 drops per minute, depending on the
intramuscular frequent blood readings. Intermittent Regitine had been unsuccessful in
their patient. On the other hand, Emanuel et al'" warn that the drug does not seem to
protect humans from arrhythmias induced by pressor amines.
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The operating team should be well prepared for the emergencies that are apt
to arise. Continuous monitoring of the blood pressure by an intraarterial cannula is
probably worth while. The anesthetic agent and body position must be chosen
carefully.'"-"' When anesthesia is induced and the incision is made, blood pressure
rises to various degrees. Five mgs. of Regitine IV may be advisable at this time.
Various surgical approaches are used. A high transverse abdominal incision permits
wide exploration.'"
The tumor should be treated gently and its vessels ligated early. As it is
palpated, 5 mgs. or more of Regitine may be used to control paroxysms.* With tying
of the vessels, shock often occurs. This is controlled by the administration of pressor
agents sufficient to maintain the blood pressure at about 100/70 to 110/80.'" It is
probably even advisable to make the fall a gradual one by giving these drugs relatively
early.' I f no drop occurs, the surgeon should search for additional tumor tissue.'"
Preservation of some adrenal cortex is important. I f this cannot be done, intravenous
hydrocortisone should be at hand.'"
After surgery Thorne"' recommends leaving the patient undisturbed on the operating table for several hours. Extremely close observation is still necessary, for the
blood pressure may drop unexpectedly.'" Urinary catecholamine determination will
help assess the completeness of the operation."'
PROGNOSIS
Untreated pheochromocytomas are generally fatal in a few years, their course
resembling that of malignant hypertension."' Death is usually caused by pulmonary
edema, coma, cerebral hemorrhage, or shock during surgery or other circumstances."-'"
The author is aware of one report of fatal hemorrhage into a previously asymptomatic
tumor."
When found in relation to pregnancy, the disease may be fatal before or after
parturition, often within a day of delivery. The overall maternal mortality has been
about 50%, while that for the infant is approximately 40%.'-'-"
The fatahty rate in childhood is about 54%.'"
Surgical removal of the tumor often results in cure. Partial or complete
reversal of the changes in the circulatory system may result. I f hypertension persists,
the possible causes include the presence of additional tumors or metastases, irreversible
vascular damage due to previous hypertension, and the presence of essential hypertension. Operative mortality has been 20 or 30%, but will probably decline with
improved understanding of the disease."-"' Many of the deaths are due to shock
which is seen during 10 to 50% of operations when the veins draining the tumor
are ligated. This is believed due to the sudden deprivation of the large amount of
pressor amines to which the organism has adapted. Disuse atrophy of the other adrenal
medulla and surgical injury of the adrenal cortex may be contributing factors.'-"
Spontaneous shock has also been described. Whether this is due to sudden cessation
*Benzodioxane and dibenamine have also been employed to control the blood pressure during
surgery."
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of secretion or is related to the shock-like state seen in epinephrine-infused animals
is uncertain. Several reports describing such crises are in the literature. In some
patients, deep shock alternates with bouts of severe hypertension.'-"-"' Rarely shock
appears as the presenting difficulty." One report describes the appearance of shock
following intramuscular administration of 10 mgs. of prochlorperazine.' The tumor
may be infarcted and become functionless during the hypotensive episode.
Other complications include loss of vision, congestive failure, myocardial infarction, basilar thrombosis, severe diabetes, and, of course, the usual sequelae of
hypertension.'"-"-'" Rarely, Addison's disease may result from compression of the
adrenal cortex."-" As already implied, when significant levels of pressor amines have
been present long enough, hypertension may no longer depend on them, and may
persist after otherwise successful surgery."'
SUMMARY
The diagnostic and therapeutic problems associated with pheochromocytoma are
presented in detail. It is hoped that this will encourage increased recognition and
more successful management

of these tumors.
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